InvestorsHub Logo
icon url

Nanotoday

02/16/18 11:33 PM

#137819 RE: arvitar #137816

I’m sorry but saying it has been done for other nanoparticle therapeutics so it can be done for the ligand and backbone viricide composition/construction is assuming that all nano therapeutics are design identically.

They are not.